World Infusion Pumps Market 2014

World Infusion Pumps Market 2014
THE WORLD INFUSION PUMPS MARKET WILL REACH $7.74BN IN 2014 London, UK, 30th OCTOBER 2014: visiongain predicts the world market for infusion pumps will reach $7.74bn in 2014. This forecast and others appear in Infusion Pumps Market Forecast 2014-2024: Prospects for Leading Companies, published in October 2014. Visiongain predicts that the infusion pumps market will ...

Automation & Robotics in Auto Manufacturing 2014

Automation & Robotics in Auto Manufacturing 2014
AUTOMATION & ROBOTICS IN AUTOMOTIVE MANUFACTURING TO REACH $13.66 BILLION IN 2014 London, UK. 29th OCTOBER 2014: Visiongain’s analysis indicates that the market value of automation & robotics in automotive manufacturing will reach $13.66bn in 2014. Strong growth throughout 2014-2024 is expected as demand for automation equipment and industrial robots which improve productivity and reduce ...

Food Traceability Technologies 2015

Food Traceability Technologies 2015
THE FOOD TRACEABILITY TECHNOLOGIES MARKET WILL REACH $11.15 BN IN 2015 London, UK, 29th of OCTOBER 2014: A new report by visiongain predicts that the world market for the food traceability technologies will reach $11.15bn in 2015. This forecast and others appear in Food Traceability Technologies Market 2015-2025: EAN / UPC Barcodes, 2D QR Codes, ...

Electronic Warfare (EW) Market 2014

Electronic Warfare (EW) Market 2014
ELECTRONIC SUPPORT SYSTEMS  SET TO BE FASTEST GROWING ELECTRONIC WARFARE (EW) MARKET AS GROWING THREATS DRIVE SPENDING London, UK. 28th OCTOBER 2014: The electronic warfare market has returned to the limelight for various reasons including ongoing modernisation in developing countries and increasing asymmetric combatant access to high-quality equipment. These reasons will impact on the development ...

Asthma & COPD Therapies 2014

Asthma & COPD Therapies 2014
THE WORLD ASTHMA AND COPD THERAPIES MARKET WILL REACH $33.1BN IN 2014 London, UK, 27th OCTOBER 2014: A new report by visiongain predicts that the world market for asthma and COPD therapies will reach $33.1bn in 2014. This forecast and others appear in Asthma and COPD Therapies Market Forecast 2014-2024: Opportunities for Leading Companies. Asthma ...

Flat Glass Opportunities for Leading Companies 2014

Flat Glass Opportunities for Leading Companies 2014
THE WORLD MARKET FOR FLAT GLASS WILL REACH $83 BILLION IN 2014 London, UK. 24th OCTOBER 2014: visiongain determines that the world market for flat glass will reach $83bn in 2014. This forecast and others appear in Flat Glass Market Report 2014-2024: Opportunities For Leading Companies in Building, Construction, Automotive & Solar Energy. As the ...

NEW YORK SUFFERS FIRST EBOLA CASE AS MAN BROUGHT TO HOSPITAL

A New York City doctor has tested positive for Ebola after returning from aid work in West Africa; authorities are tracking his movements and reassuring the public the risk of contracting the disease is minimal, Bloomberg reports. It is the first case of Ebola diagnosed in the most populous US city. The doctor, Craig Spencer, ...

J&J WINS FIRST PINNACLE HIP IMPLANT TRIAL

A J&J unit’s design of a metal-on-metal version of its Pinnacle hip implants is not defective, a Dallas jury concluded, ruling against a woman who said the devices poisoned her in the first case of its kind to go to trial, Bloomberg reports. The ULTAMET artificial hips sold by J&J’s DePuy subsidiary as part of ...

ASTRAZENECA OVARIAN CANCER DRUG WINS EUROPEAN GREEN LIGHT

AstraZeneca’s cancer drug pipeline received a boost 24th October as European regulators recommended approval of an experimental medicine against ovarian cancer, Reuters reports. The green light from the EMA for olaparib, or Lynparza, is welcome news since the product hit a road bump in June when a US panel voted against its accelerated approval. AstraZeneca ...

US COURT UPHOLDS PATENTS ON PFIZER’S CANCER DRUG

A US district court ruled in favor of Pfizer in a patent lawsuit it filed against Mylan alleging patent infringement on its cancer drug, Sutent, according to Pfizer, Reuters reports. Pfizer filed the lawsuit in June 2010 after Mylan attempted to market a generic version of Sutent, patented until 2021. Sutent, which is approved for ...